Low Frequency of Second Autologous STEM CELL Transplantation (ASCT) for Multiple Myeloma (MM) Patients (PTS) Aged 65 YEARS and ABOVE in the Modern EraPrajwol Pathak, Maxim Norkin, Fei Zou et al.|Transplantation and Cellular Therapy|2016Cited by 0
Impact of Novel Agents on Frequency of Second Salvage Autologous Transplantation in Patients with Multiple MyelomaPrajwol Pathak, Maxim Norkin, Athira Unnikrishnan et al.|Blood|2016Cited by 0